Prosecution Insights
Last updated: April 19, 2026

Global Blood Therapeutics Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
3
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18019379 UREA DERIVATIVES AS PYRUVATE KINASE ACTIVATORS RODRIGUEZ, RAYNA B 1628 Non-Final OA Feb 02, 2023
17991448 MODULATORS OF HEMOGLOBIN JARRELL, NOBLE E 1699 Final Rejection Nov 21, 2022
17997273 METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS LEE, CHIHYI NMN 1628 Final Rejection Oct 27, 2022
17777909 METHODS OF ADMINISTERING VOXELOTOR SANCHEZ, JUSTIN CHRISTOPHER 1622 Final Rejection May 18, 2022

Managing Global Blood Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month